OEP backs InfuCare, betting complex chronic conditions will drive demand for home-based care

"Infusion therapy delivered in the home provides patients with the lowest cost of care relative to other alternatives and is always preferred by the patient," said One Equity Partners' Greg Belinfanti.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this